Pular para o conteúdo

Interações medicamentosas

Blinatumomab + Siponimod

Gravidade: Moderada

Blinatumomab and Siponimod: moderate interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

O que esta interação significa em palavras simples

Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Blinatumomab belongs to Oncology; Siponimod belongs to Central Nervous System.

Nível de evidência: Low

Por que acontece

Additive immune suppression from B-cell depletion and S1P-mediated lymphocyte sequestration.

O que fazer

Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

O que perguntar ao farmacêutico

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Blinatumomab e Siponimod, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Blinatumomab with Siponimod?

MediHelp rates the interaction as moderate. Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

How serious is the interaction between Blinatumomab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar